Free Trial

OrthoPediatrics (KIDS) Competitors

OrthoPediatrics logo
$19.20 +1.30 (+7.26%)
Closing price 08/7/2025 04:00 PM Eastern
Extended Trading
$19.20 0.00 (0.00%)
As of 08/7/2025 05:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

KIDS vs. EYE, LMAT, LQDA, CNMD, ENOV, SSII, CDRE, NVCR, AORT, and ESTA

Should you be buying OrthoPediatrics stock or one of its competitors? The main competitors of OrthoPediatrics include National Vision (EYE), LeMaitre Vascular (LMAT), Liquidia Technologies (LQDA), CONMED (CNMD), Enovis (ENOV), SS Innovations International (SSII), Cadre (CDRE), NovoCure (NVCR), Artivion (AORT), and Establishment Labs (ESTA). These companies are all part of the "medical equipment" industry.

OrthoPediatrics vs. Its Competitors

OrthoPediatrics (NASDAQ:KIDS) and National Vision (NASDAQ:EYE) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, earnings, dividends, profitability, analyst recommendations, valuation and risk.

National Vision has a net margin of -0.75% compared to OrthoPediatrics' net margin of -18.92%. National Vision's return on equity of 3.56% beat OrthoPediatrics' return on equity.

Company Net Margins Return on Equity Return on Assets
OrthoPediatrics-18.92% -6.35% -4.75%
National Vision -0.75%3.56%1.49%

69.1% of OrthoPediatrics shares are held by institutional investors. 32.7% of OrthoPediatrics shares are held by insiders. Comparatively, 2.7% of National Vision shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

National Vision has higher revenue and earnings than OrthoPediatrics. National Vision is trading at a lower price-to-earnings ratio than OrthoPediatrics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OrthoPediatrics$204.73M2.28-$37.82M-$1.79-10.73
National Vision$1.82B1.05-$28.50M-$0.33-73.24

OrthoPediatrics has a beta of 1.12, meaning that its share price is 12% more volatile than the S&P 500. Comparatively, National Vision has a beta of 1.27, meaning that its share price is 27% more volatile than the S&P 500.

In the previous week, National Vision had 9 more articles in the media than OrthoPediatrics. MarketBeat recorded 25 mentions for National Vision and 16 mentions for OrthoPediatrics. National Vision's average media sentiment score of 1.14 beat OrthoPediatrics' score of 0.11 indicating that National Vision is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
OrthoPediatrics
2 Very Positive mention(s)
1 Positive mention(s)
8 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral
National Vision
9 Very Positive mention(s)
7 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

OrthoPediatrics presently has a consensus target price of $36.29, indicating a potential upside of 88.99%. National Vision has a consensus target price of $24.73, indicating a potential upside of 2.31%. Given OrthoPediatrics' stronger consensus rating and higher probable upside, analysts clearly believe OrthoPediatrics is more favorable than National Vision.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OrthoPediatrics
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.86
National Vision
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.60

Summary

National Vision beats OrthoPediatrics on 9 of the 15 factors compared between the two stocks.

Get OrthoPediatrics News Delivered to You Automatically

Sign up to receive the latest news and ratings for KIDS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KIDS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KIDS vs. The Competition

MetricOrthoPediatricsMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$434.73M$6.80B$5.48B$9.57B
Dividend YieldN/A1.35%4.00%4.18%
P/E Ratio-10.7324.4429.8825.14
Price / Sales2.2858.73440.45103.02
Price / CashN/A20.5535.9458.58
Price / Book1.315.528.105.59
Net Income-$37.82M$178.18M$3.26B$265.48M
7 Day Performance-5.84%-0.57%0.65%1.22%
1 Month Performance-11.44%-5.36%2.44%0.39%
1 Year Performance-32.11%6.18%27.59%23.47%

OrthoPediatrics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KIDS
OrthoPediatrics
3.8976 of 5 stars
$19.20
+7.3%
$36.29
+89.0%
-29.2%$434.73M$204.73M-10.73200Earnings Report
Analyst Forecast
EYE
National Vision
3.0375 of 5 stars
$24.48
-2.2%
$23.00
-6.0%
+121.1%$1.98B$1.82B-74.1813,411Trending News
Earnings Report
Analyst Forecast
LMAT
LeMaitre Vascular
2.3761 of 5 stars
$82.47
+0.0%
$97.83
+18.6%
+17.4%$1.86B$219.86M41.65490Trending News
Earnings Report
Analyst Forecast
Analyst Revision
LQDA
Liquidia Technologies
3.4698 of 5 stars
$19.82
+1.1%
$26.89
+35.7%
+79.9%$1.68B$14M-12.5450Insider Trade
CNMD
CONMED
4.4058 of 5 stars
$50.05
-1.8%
$62.20
+24.3%
-19.9%$1.58B$1.32B13.173,900
ENOV
Enovis
3.1716 of 5 stars
$27.36
-0.7%
$55.60
+103.2%
-29.8%$1.57B$2.11B-1.967,367News Coverage
Earnings Report
SSII
SS Innovations International
N/A$7.20
+0.3%
N/AN/A$1.39B$20.65M0.004Gap Up
CDRE
Cadre
3.1377 of 5 stars
$33.60
-0.9%
$37.50
+11.6%
-5.1%$1.38B$567.56M35.372,284News Coverage
Earnings Report
NVCR
NovoCure
4.576 of 5 stars
$11.64
-3.3%
$28.79
+147.3%
-40.1%$1.34B$605.22M-7.461,488
AORT
Artivion
1.8943 of 5 stars
$31.32
-0.3%
$32.40
+3.4%
+30.4%$1.34B$388.54M-62.641,600News Coverage
Earnings Report
ESTA
Establishment Labs
1.7458 of 5 stars
$42.48
+0.2%
$54.83
+29.1%
+1.1%$1.23B$166.02M-13.701,018News Coverage
Earnings Report

Related Companies and Tools


This page (NASDAQ:KIDS) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners